Work on the next major piece in the development of Mason's biohealth corridor along I-71 got underway Tuesday. AtriCure leaders and employees along with city officials held a groundbreaking ceremony for the company's new global headquarters. CEO Mike Carrel says the new headquarters is significant on several fronts:
- It gives the company more room to grow and further develop medical devices for treating atrial fibrillation
- It allows the company to help patients worldwide who have Afib
- It helps Mason from an economic standpoint and keeps jobs in the U.S. and Ohio
The company is building its 85,000-square-foot headquarters on a 10-and-a-half acre campus in Mason's OakPark District. It's relocating its headquarters with more than 200 employees from West Chester.
Mason's economic development director and port authority executive director , Michele Blair, says AtriCure represents "iterative growth" in the city's bioscience/biohealth district. She lists companies that are already involved:
- Seapine Software
- Festo
- Fanuc Robotics
- C.R. Bard
- Stress Engineering
- Luxotica/EyeMed
Blair calls AtriCure a "significant move in the right direction."
The company's new headquarters will be completed in late 2015/early 2016.